Our Story

Discover the story behind Metabolomycs, Inc. and our dedication to advancing metabolomics research.

Our journey began with a vision to make meaningful contributions to scientific discovery and healthcare innovation. We entered the exciting field of metabolomics by initially looking at metabolites of cancer patients and healthy patients. What we found were patterns that clearly identified if someone had a particular cancer and, more importantly, if they were on the path to getting that particular cancer. We performed clinical trials here in the US and Brazil, patented our work, and studied other diseases and metabolic irregularities. Through this research we found how to analyze a person's metabolites which can be used in diagnosing current and future health problems.

As a team, we are driven by the desire to unravel the complexities of metabolics and translate our findings into tangible benefits for society. With a focus on cutting-edge technology and interdisciplinary collaboration, we strive to differentiate ourselves and lead the way in metabolomics research and development.

Meet Our Experienced Team of Medical & Business Professionals

Under the leadership of Dr. Robert Nagourney, our team has amassed decades of experience in Oncology, Hematology, Molecular biology, Metabolomics and Mass spectrometry.

Dr N cropped in lab

Robert Nagourney, MD

Founder

Founder, CEO of Nagourney Cancer Institute Internationally recognized for his pioneering work in human phenotypic analysis Read More
ismael-dale-cotrim-da-silva

Ismael Dale Cotrim da Silva, MD, PhD

Co-Founder

Senior Advisor and Coordinator of Molecular Biology at Fleury Laboratories. Holds several international patents in cancer and non-malignant diseases. Read More
Paulo D'Amora, MD, PhD

Paulo D'Amora, MD, PhD

Research Director

Award-winning researcher from Sao Paulo State Research Foundation; Directs research on NextGen Metabolomics between US and Brazil research centers. Read More
Steve Evans

Steven Evans, BS, MA

Lab Director

COO, Nagourney Cancer Institute, Former Senior Research Scientist at Todd Cancer Institute in Long Beach, CA Read More
Rhoderic Bannatyne

Rhoderic Bannatyne

Chief Financial Officer

CFO - Vidimetrics Ltd, Caliper; Auditor with KPMG UK; experience with SaaS & Biotech ventures in Europe & US. Read More
Glenn Bernstein

Glenn Bernstein, MBA

Director - Marketing & Business Development

Glenn Bernstein, MBA - Marketing Director at Nagourney Cancer Institute, former Regional Sales Mgr. at American Home Shield, Business Strategist improving companies throughout US, Canada. Read More
Dr N cropped in lab
Founder

Robert Nagourney, MD

Founder, CEO of Nagourney Cancer Institute Internationally recognized for his pioneering work in human phenotypic analysis

ismael-dale-cotrim-da-silva
Co-Founder

Ismael Dale Cotrim da Silva, MD, PhD

Senior Advisor and Coordinator of Molecular Biology at Fleury Laboratories. Holds several international patents in cancer and non-malignant diseases.

Paulo D'Amora, MD, PhD
Research Director

Paulo D'Amora, MD, PhD

Award-winning researcher from Sao Paulo State Research Foundation; Directs research on NextGen Metabolomics between US and Brazil research centers.

Steve Evans
Lab Director

Steven Evans, BS, MA

COO,  Nagourney Cancer Institute, Former Senior Research Scientist at Todd Cancer Institute in Long Beach, CA

Rhoderic Bannatyne
Chief Financial Officer

Rhoderic Bannatyne

CFO - Vidimetrics Ltd, Caliper; Auditor with KPMG UK; experience with SaaS & Biotech ventures in Europe & US.

Glenn Bernstein
Director - Marketing & Business Development

Glenn Bernstein, MBA

Glenn Bernstein, MBA - Marketing Director at Nagourney Cancer Institute, former Regional Sales Mgr. at American Home Shield, Business Strategist improving companies throughout US, Canada.